COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

May 27, 2020

Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection

Experimental and Molecular Pathology
Ehud Lavi, Lin Cong
May 26, 2020
PreprintOpen Access

SARS-CoV-2 IgG Antibody Responses in New York City

J. ReiferVincent A Streva
May 24, 2020
PreprintOpen Access

A systems approach to inflammation identifies therapeutic targets in SARS-CoV-2 infection

F. L. van de VeerdonkL. A. B. Joosten
May 28, 2020

Lymphopenia in COVID-19: Therapeutic Opportunities

Cell Biology International
Nazanin Fathi, Nima Rezaei
May 28, 2020

COVID-19 encephalopathy masquerading as substance withdrawal

Journal of Medical Virology
Sean ByrnesIan Dargon
May 28, 2020
Open Access

Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis

International Journal of Environmental Research and Public Health
Maria MirabelliAntonio Brunetti
May 27, 2020

Design of a Novel Multi Epitope-Based Vaccine for Pandemic Coronavirus Disease (COVID-19) by Vaccinomics and Probable Prevention Strategy against Avenging Zoonotics

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Sajjad AhmadSyed Sikander Azam
May 23, 2020
ReviewOpen Access

COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation

Ioannis ZabetakisAlexandros Tsoupras
May 27, 2020

Emerging pharmacotherapies for COVID-19

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Rachana Salvi, Panini Patankar
May 26, 2020
Comment / Editorial

Reply to letter: Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Álvaro Beltrán-CorbelliniAraceli Alonso-Cánovas
May 23, 2020
ReviewOpen Access

The COVID-19 Pandemic during the Time of the Diabetes Pandemic: Likely Fraternal Twins?

Shelley A ColeRaul A Bastarrachea
May 26, 2020

Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Peng-Jiao AnLi-Ping Yang
May 26, 2020

A review on possible modes of actions of Chloroquine/ Hydroxychloroquine: Repurposing against SAR-COV-2 (COVID 19) pandemic

International Journal of Antimicrobial Agents
Satyajit TripathyMotlalepula Gilbert Matsabisa
May 27, 2020

Extracorporeal Hemoadsorption: An Option for COVID-19 Associated Cytokine Storm Syndrome

L Christian Napp, Johann Bauersachs
May 28, 2020

Mechanistic inferences from clinical reports of SARS-CoV-2

Infectious Diseases
Meagan M JenkinsPaul A Goepfert
May 25, 2020
PreprintOpen Access

SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T-cell receptors

A. S. ShomuradovaGrigory A Efimov

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

COVID-19 Neurologic Manifestations

COVID-19 patients frequently have neurological symptoms, which are probably caused by the virus invading the central nervous system. Symptoms range from a loss of smell and taste to serious complications such as encephalitis, many of which are associated with poor prognosis. This feed follows the latest developments and research into the neurological complications associated with COVID-19.

© 2020 Meta ULC. All rights reserved